• Return to Headlines

Karyopharm Thera Has Returned 33.2% Since SmarTrend Recommendation (KPTI)

By Nick Russo

SmarTrend identified a Downtrend for Karyopharm Thera (NASDAQ:KPTI) on September 27th, 2018 at $17.38. In approximately 1 month, Karyopharm Thera has returned 33.24% as of today's recent price of $11.60.

In the past 52 weeks, Karyopharm Thera share prices have been bracketed by a low of $9.00 and a high of $21.71 and are now at $11.60, 29% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 4.8% while the 200-day MA has remained constant.

Karyopharm Therapeutics, Inc. provides biopharmaceutical products and services. The Company develops and discovers drugs for the treatment of cancer, inflammation, and diseases related to cell proliferation through activity modulation of critical pathways. Karyopham Therapeutics serves the healthcare industry throughout the United States and Germany.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Karyopharm Thera.

Log in and add Karyopharm Thera (KPTI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights karyopharm thera

Ticker(s): KPTI